Aashka Hospitals Limited is a multi-specialty tertiary care healthcare provider headquartered in **Gandhinagar, Gujarat**. Established in **2012**, the company operates a comprehensive medical ecosystem integrating inpatient and outpatient care, advanced surgical capabilities, and full-scale pharmaceutical retail. The company is currently undergoing a significant corporate evolution, transitioning from the **BSE SME platform** to the **Main Board of the BSE** and seeking a **Direct Listing on the National Stock Exchange (NSE)**. --- ### **Infrastructure and Clinical Capabilities** The company operates an advanced medical center situated on **3,060 Sq. Mts.** of land in Sargasan, Gandhinagar. The facility is designed to meet high-acuity clinical requirements with a focus on super-specialty care. | Feature | Specification | | :--- | :--- | | **Total Bed Capacity** | **150 Beds** | | **ICU Capacity** | **65 Beds** (Intelligent ventilators & central gas supply) | | **Operating Theatres (OT)** | **6 Units** (2 Cardiac OTs, 4 Super-specialty OTs) | | **OT Standards** | **Class 100 modular**, Laminar airflow, HEPA filters | | **Diagnostic Suite** | Flat panel **Cath Lab**, **CT Scan**, Endoscopy rooms | | **Logistics Tech** | Pneumatic transfer system & software-driven administration | --- ### **Revenue Streams and Service Delivery Model** Aashka Hospitals utilizes a cost-effective, high-quality delivery model with diversified income sources: * **Hospital Services:** Revenue generated from Inpatient (IPD) and Outpatient (OPD) services, including room charges, theatre fees, and radiology/laboratory diagnostics. * **Professional Services:** Fees derived from specialized medical consultations and complex surgical procedures. * **Pharmacy Operations:** Direct-to-patient sales of pharmaceutical goods and medicines through in-house pharmacies. * **Revenue Recognition Policy:** Income is recognized on an **accrual basis**. Notably, the company records **unbilled revenue** for patients receiving treatment who have not yet been discharged at the end of a reporting period. --- ### **Strategic Growth Drivers and Market Positioning** The company is positioning itself to capitalize on the Indian healthcare market, which reached **$372 Billion** following a **22% CAGR (2016-2022)**. * **Exchange Migration:** The transition to the **Main Board** (supported by a paid-up capital of **₹23.40 Crore** across **2.34 Crore shares**) is intended to enhance **liquidity**, build **brand equity**, and attract **institutional investors**. * **Corporate Partnerships:** Aashka is expanding its footprint through strategic empanelments, including a recent agreement to provide healthcare services to the staff of **Gujarat International Finance Tec-City (GIFT City)**. * **Government Scheme Integration:** Active participation in the **Ayushman Bharat (ABPMJAY)** scheme, providing coverage up to **₹5 lakh** per family, ensures a steady volume of patient inflow. * **Digital Transformation:** The company is accelerating the adoption of **telemedicine**, **AI-driven diagnostics**, and **IoT** for patient monitoring to improve clinical outcomes and operational efficiency. --- ### **Financial Performance and Recovery** The company demonstrated a significant financial turnaround in the most recent fiscal year, moving from a loss-making position to profitability. | Financial Metric | FY 2023-24 | FY 2022-23 | Growth (%) | | :--- | :--- | :--- | :--- | | **Total Earnings** | **₹22.87 Crore** | **₹18.94 Crore** | **+20.75%** | | **Profit / (Loss) After Tax** | **₹2.36 Crore** | **(₹2.57 Crore)** | **Turnaround** | **Key Financial Observations:** * **Profitability:** The company successfully reversed a **₹2.57 Crore loss** to achieve a **Net Profit of ₹2.36 Crore** in **FY 2024**. * **Asset Security:** Banking facilities with the **Bank of India** are secured by the hypothecation of plant, machinery, and book debts, alongside the equitable mortgage of the Gandhinagar hospital. * **Collateral Base:** Promoters have provided extensive collateral, including **66,155 Sq. Mts.** of land in **Dharmoda** and multiple plots in **Dharisana**. --- ### **Operational Efficiency and Sustainability** Aashka is integrating "smart" technologies and green initiatives to optimize margins: * **Energy Conservation:** Transitioning to **LED lighting**, high-efficiency motors, and planned **solar power** for domestic usage. * **Resource Optimization:** Plans are underway to utilize **process waste heat** to reduce natural gas consumption. * **Governance Strengthening:** To meet Main Board standards, the company appointed **Mr. Jigar Kanakchandra Trivedi** as an **Independent Director** through **October 2029**. --- ### **Critical Risk Factors and Governance Challenges** Investors should note several material risks and historical regulatory lapses identified in audit reports: **1. Financial and Audit Qualifications** * **Going Concern Uncertainty:** Auditors have previously expressed doubt regarding the company’s ability to continue as a **going concern** unless it recovers substantial outstanding advances. * **Interest Recognition Issues:** In **FY 2023**, auditors issued a **Qualified Opinion** because the company recognized **₹3.06 Crore** in interest on advances, yet lacked confirmation for **₹2.13 Crore** of that balance. * **Unrecovered Advances:** As of **September 2023**, the company had **₹34.14 Crore** in outstanding advances. This includes a **₹28.67 Crore** advance made to a **Director** in FY 2021-22 that remains outstanding without a sale deed. **2. Regulatory and IPO Compliance** * **Misutilization of Funds:** The company failed to utilize **₹9.72 Crore** from Public Issue proceeds specifically earmarked for **Bank Loan repayment**. * **Administrative Lapses:** Historical non-compliance includes delays in filing financial results, failure to appoint a **CFO** and **Independent Directors** within statutory timelines, and unresolved **SCORES complaints**. **3. Industry and Macro Risks** * **Regulatory Pressure:** Increasing government **price controls** on medicines and implants may compress margins. * **Cybersecurity:** The shift to digital health increases vulnerability to **ransomware and data breaches**. * **Workforce Constraints:** A national shortage of **skilled doctors and nurses** remains a primary bottleneck for scaling operations. * **Market Consolidation:** Intense competition from large corporate hospital chains may lead to pricing pressure or necessitate further capital-intensive expansion.